WHO ICTRP trial
Randomized, placebo-controlled, double-blind study to evaluate the influence of…
DRKS00010276 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00010276 |
|---|---|
| Public title | Randomized, placebo-controlled, double-blind study to evaluate the influence of a combination product with L-arginine, folic acid, vitamin b6 and vitamin b12 on endothelial function in people with mild to moderate blood pressure elevation. |
| Scientific title | Randomized, placebo-controlled, double-blind study to evaluate the influence of a combination product with L-arginine, folic acid, vitamin b6 and vitamin b12 on endothelial function in people with mild to moderate blood pressure elevation. |
| Primary sponsor | QUIRIS Healthcare GmbH & Co. KG |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Germany |
| Conditions | mild to moderate elevated blood pressure I10;Essential (primary) hypertension |
| Interventions | Group 1: Treatment (dietary management): 2x daily 2 tablets (per day: 2.4 g L-arginine, 3 mg vitamin B6, 0.4 mg folic acid, 2 µg vitamin B12) Study phase I: randomized, placebo-controlled, double-blind study with parallel design over 3… |
| Registration date | Jul 4, 2016 |
| Target size | 81 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: